BMO Capital Markets Focused on Expanding Healthcare Franchise
BMO Capital Markets has appointed Evan Seigerman as Managing Director and Senior Equity Research Analyst, focusing on biotechnology and pharmaceuticals. This hire aligns with BMO's strategy to enhance its healthcare franchise, which supports various financial services in the healthcare sector. Mr. Seigerman brings over a decade of experience from Credit Suisse, Barclays Capital, and Deutsche Bank. Additionally, Trung Huynh is joining to bolster the research team. BMO Capital Markets, part of BMO Financial Group, aims to deepen its healthcare expertise and client relationships.
- Hiring Evan Seigerman enhances BMO's healthcare expertise.
- Expansion of the healthcare research franchise may lead to increased client services and revenue.
- None.
- Hires Evan Seigerman to cover biotech and pharma as part of plans to deepen expertise and help drive growth
NEW YORK, June 22, 2021 /PRNewswire/ - BMO Capital Markets, the investment & corporate banking arm of BMO Financial Group (NYSE: BMO) (TSX: BMO), today announced that it has hired Evan Seigerman as a Managing Director and Senior Equity Research Analyst covering the biotechnology and pharmaceutical industries.
Mr. Seigerman's hire is a key part of BMO's ongoing strategy to build out its healthcare franchise to meet the needs of clients. BMO continues to deepen its expertise and expand services in healthcare across the enterprise -- including Capital Markets, Business and Commercial Banking and Wealth -- where it has deep ties with clients from service providers to biotech innovators, and offers dedicated banking services to help healthcare professionals grow their businesses and manage their finances.
Mr. Seigerman will be based in New York and report to Bert Powell, Global Director of Equity Research. He will drive the expansion of BMO's healthcare research franchise, which currently consists of four analysts – including Mr. Seigerman – as well as:
- Gary Nachman, who covers BioPharma/Biotechnology;
- Matthew Luchini, who covers Biotechnology; and,
- Matt Borsch, CFA, who covers Managed Care/Providers.
"Evan brings a deep understanding of the biotech sector across market caps and therapeutic areas," said Mr. Powell. "In addition, he brings a client-centric focus with the vision to build a market-leading research franchise."
Mr. Seigerman has over a decade of experience, most recently at Credit Suisse in New York where he covered the U.S. biopharmaceuticals sector. He has worked at Barclays Capital and Deutsche Bank Securities, also in New York, and was selected by Business Insider as a 2021 "Rising Star" of equity research.
In addition to Mr. Seigerman, Trung Huynh is joining the BMO healthcare research team to support the firm's expansion and growth. Mr. Huynh has more than ten years of experience covering therapeutic and pharmaceutical companies, and most recently was with Credit Suisse in London. He holds degrees from Imperial College and Loughborough University.
About BMO Capital Markets
BMO Capital Markets is a leading, full-service North American-based financial services provider offering equity and debt underwriting, corporate lending and project financing, merger and acquisitions advisory services, securitization, treasury management, market risk management, debt and equity research and institutional sales and trading. BMO Capital Markets has approximately 2,600 professionals in 33 locations around the world, including 18 offices in North America.
BMO Capital Markets is a member of BMO Financial Group (NYSE, TSX: BMO), one of the largest diversified financial services providers in North America with US
View original content:http://www.prnewswire.com/news-releases/bmo-capital-markets-focused-on-expanding-healthcare-franchise-301317046.html
SOURCE BMO Financial Group
FAQ
Who has been hired by BMO Capital Markets to focus on biotech and pharma?
What is the aim of BMO Capital Markets' recent hires?
Where is Evan Seigerman based?
What experience does Evan Seigerman bring to BMO?
What is the total asset value of BMO Financial Group?
